Clinical trial
Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and…
NCT00307879 · Seoul National University Hospital, Other · Terminated
Key facts
| NCT number | NCT00307879 |
|---|---|
| Title | Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion |
| Official title | Phase 2 MAGIC Cell (Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion) Trial |
| Lead sponsor | Seoul National University Hospital, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug, Procedure |
| Interventions | Drug: G-CSF (Dong-A pharmaceutical, Seoul, Korea), collection of mobilized peripheral blood stem cells, Intracoronary infusion of mobilized cells |
| Enrollment | 20 |
| Start date | Mar 1, 2004 |
| Completion | Feb 1, 2005 |
| First posted | Mar 28, 2006 |
| Last update posted | Mar 28, 2006 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: